Fuse Science, Inc. Strengthens Board of Directors with Addition of Seasoned Executives

Aug 20, 2013, 11:16 ET from Fuse Science, Inc.

MIAMI LAKES, Fla., Aug. 20, 2013 /PRNewswire/ -- Fuse Science, Inc. (OTCQB: DROP) (www.fusescience.com), a consumer products and delivery technology company that is developing new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals announced today the addition of Ms. JoAnne Brandes and Mr. Reginald Hollinger to the Fuse Science, Inc. board as independent directors and the appointment of Jeanne Hebert, Senior VP of Marketing and Clinical Research to a board seat.  This is the second phase of the Company's continuing efforts to expand dedicated resources while reducing corporate expenses.

"We are very pleased to welcome Mr. Hollinger and Ms. Brandes to our board of directors.  Their extensive experience in corporate finance, mergers and acquisitions, and legal and administrative matters strengthens our corporation significantly," stated Brian Tuffin, CEO of Fuse Science, Inc.  

Reginald Hollinger has over 23 years of experience in the fields of mergers and acquisitions and corporate finance.  Since 2012, he has been an independent consultant in the field, after having served as a Managing Director at SunTrust Robinson Humphrey, Inc. from 2011 to 2012 and as a co-founder and Managing General Partner of Quetzal/J.P. Morgan Partners, L.P., a New York City-based private equity fund from 2000 to 2010.  Mr. Hollinger holds a B.A. from Williams College and an M.B.A. from Harvard Business School. 

JoAnne Brandes is an attorney and consultant specializing in leadership development, corporate structure and governance, cultural transformation and change management.  In January 2007, she retired from an over 25-year career with the S.C. Johnson family of companies, where she served in various capacities, including the Executive Vice President, Chief Administrative Officer, General Counsel and Secretary of JohnsonDiversey, Inc., responsible for all legal matters, human resources, communications, public offerings and administration for the firm and its over 65 domestic and international subsidiaries.  She currently serves as a member of the board of directors of Andersen Windows Corporation, Bemis Manufacturing Corporation and First Business Bank of Brookfield, Wisconsin.  Ms. Brandes holds a B.A. degree from the University of Wisconsin and a J.D. degree from Willamette University College of Law. 

"The Fuse Science board is now comprised of nine members, seven independent directors and two management directors," stated Brian Tuffin, CEO of Fuse Science.  "The governance of our company is a best practice model for shareholders and these new additions strengthen an existing team that will help advance the active strategies of the company with a reduced cost structure.  In the near future we anticipate the announcement of additional initiatives that we believe will assist in the continuing growth and expansion of the company," added Tuffin.

A full summary is detailed in the Company's Form 8-K, which is available on the Company's website at www.fusescience.com or within the Filings section of the Securities and Exchange Commission's web site located at www.sec.gov.  

About Fuse Science, Inc.

Fuse Science, Inc. (OTCQB: DROP), is an innovative consumer products and delivery technology company based in Miami Lakes, Florida.  Fuse Science holds the rights to new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals.  The Company maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly - all in a concentrated "DROP" form that is simply applied under the tongue.  The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products. Information about Fuse Science is available online at www.fusescience.com and www.poweredbyfuse.com or by calling 305-503-FUSE (3873).

For Fuse Science news as it happens, follow @FuseScience on Twitter and Like Us on Facebook!

Get all Fuse Science corporate updates sent directly to you; sign up for Fuse News Alerts HERE.


For more information:  

To schedule an interview:

Fuse Science, Inc.   

Gus DeQuesada

Investor Relations      

Michelsen Advertising

Direct: (305) 503-3873, Ext. 2  

C-305-733-1410 / 786-488-7138

Email: ir@fusescience.com 



SOURCE Fuse Science, Inc.